Global Female Sexual Dysfunction Treatment Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The global Female Sexual Dysfunction Treatment Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Female Sexual Dysfunction Treatment Drug Industry Forecast” looks at past sales and reviews total world Female Sexual Dysfunction Treatment Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Female Sexual Dysfunction Treatment Drug sales for 2024 through 2030. With Female Sexual Dysfunction Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Sexual Dysfunction Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Female Sexual Dysfunction Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Sexual Dysfunction Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Sexual Dysfunction Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Sexual Dysfunction Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Sexual Dysfunction Treatment Drug.
United States market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Female Sexual Dysfunction Treatment Drug players cover Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Sexual Dysfunction Treatment Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Female Sexual Dysfunction Treatment Drug market?
What factors are driving Female Sexual Dysfunction Treatment Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Female Sexual Dysfunction Treatment Drug market opportunities vary by end market size?
How does Female Sexual Dysfunction Treatment Drug break out by Type, by Application?
Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm.
The global Female Sexual Dysfunction Treatment Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Female Sexual Dysfunction Treatment Drug Industry Forecast” looks at past sales and reviews total world Female Sexual Dysfunction Treatment Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Female Sexual Dysfunction Treatment Drug sales for 2024 through 2030. With Female Sexual Dysfunction Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Female Sexual Dysfunction Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Female Sexual Dysfunction Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Female Sexual Dysfunction Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Female Sexual Dysfunction Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Female Sexual Dysfunction Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Female Sexual Dysfunction Treatment Drug.
United States market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Female Sexual Dysfunction Treatment Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Female Sexual Dysfunction Treatment Drug players cover Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Sexual Dysfunction Treatment Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Estrogen Therapy
- Ospemifene
- Flibanserin
- Bremelanotide
- Others
- Hospital Pharmacies
- Private Clinics
- Retail Pharmacies
- E-Commerce (B2B)
- E-Commerce (B2C)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva Pharmaceuticals
- Duchesnay
- Sprout Pharmaceuticals
- Cosette Pharmaceuticals
- Lupin
What is the 10-year outlook for the global Female Sexual Dysfunction Treatment Drug market?
What factors are driving Female Sexual Dysfunction Treatment Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Female Sexual Dysfunction Treatment Drug market opportunities vary by end market size?
How does Female Sexual Dysfunction Treatment Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Female Sexual Dysfunction Treatment Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Female Sexual Dysfunction Treatment Drug by Country/Region, 2019, 2023 & 2030
2.2 Female Sexual Dysfunction Treatment Drug Segment by Type
2.2.1 Estrogen Therapy
2.2.2 Ospemifene
2.2.3 Flibanserin
2.2.4 Bremelanotide
2.2.5 Others
2.3 Female Sexual Dysfunction Treatment Drug Sales by Type
2.3.1 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Female Sexual Dysfunction Treatment Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Type (2019-2024)
2.4 Female Sexual Dysfunction Treatment Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Female Sexual Dysfunction Treatment Drug Sales by Application
2.5.1 Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Female Sexual Dysfunction Treatment Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Female Sexual Dysfunction Treatment Drug Breakdown Data by Company
3.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Company (2019-2024)
3.1.2 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company (2019-2024)
3.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Female Sexual Dysfunction Treatment Drug Revenue by Company (2019-2024)
3.2.2 Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company (2019-2024)
3.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Company
3.4 Key Manufacturers Female Sexual Dysfunction Treatment Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Female Sexual Dysfunction Treatment Drug Product Location Distribution
3.4.2 Players Female Sexual Dysfunction Treatment Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FEMALE SEXUAL DYSFUNCTION TREATMENT DRUG BY GEOGRAPHIC REGION
4.1 World Historic Female Sexual Dysfunction Treatment Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Female Sexual Dysfunction Treatment Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Female Sexual Dysfunction Treatment Drug Sales Growth
4.4 APAC Female Sexual Dysfunction Treatment Drug Sales Growth
4.5 Europe Female Sexual Dysfunction Treatment Drug Sales Growth
4.6 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Growth
5 AMERICAS
5.1 Americas Female Sexual Dysfunction Treatment Drug Sales by Country
5.1.1 Americas Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
5.1.2 Americas Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
5.2 Americas Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
5.3 Americas Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Sexual Dysfunction Treatment Drug Sales by Region
6.1.1 APAC Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024)
6.1.2 APAC Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024)
6.2 APAC Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
6.3 APAC Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Female Sexual Dysfunction Treatment Drug by Country
7.1.1 Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
7.1.2 Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
7.2 Europe Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
7.3 Europe Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Female Sexual Dysfunction Treatment Drug by Country
8.1.1 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Female Sexual Dysfunction Treatment Drug
10.3 Manufacturing Process Analysis of Female Sexual Dysfunction Treatment Drug
10.4 Industry Chain Structure of Female Sexual Dysfunction Treatment Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Female Sexual Dysfunction Treatment Drug Distributors
11.3 Female Sexual Dysfunction Treatment Drug Customer
12 WORLD FORECAST REVIEW FOR FEMALE SEXUAL DYSFUNCTION TREATMENT DRUG BY GEOGRAPHIC REGION
12.1 Global Female Sexual Dysfunction Treatment Drug Market Size Forecast by Region
12.1.1 Global Female Sexual Dysfunction Treatment Drug Forecast by Region (2025-2030)
12.1.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Female Sexual Dysfunction Treatment Drug Forecast by Type (2025-2030)
12.7 Global Female Sexual Dysfunction Treatment Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.1.3 Pfizer Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Duchesnay
13.3.1 Duchesnay Company Information
13.3.2 Duchesnay Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.3.3 Duchesnay Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Duchesnay Main Business Overview
13.3.5 Duchesnay Latest Developments
13.4 Sprout Pharmaceuticals
13.4.1 Sprout Pharmaceuticals Company Information
13.4.2 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.4.3 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sprout Pharmaceuticals Main Business Overview
13.4.5 Sprout Pharmaceuticals Latest Developments
13.5 Cosette Pharmaceuticals
13.5.1 Cosette Pharmaceuticals Company Information
13.5.2 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.5.3 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Cosette Pharmaceuticals Main Business Overview
13.5.5 Cosette Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.6.3 Lupin Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Female Sexual Dysfunction Treatment Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Female Sexual Dysfunction Treatment Drug by Country/Region, 2019, 2023 & 2030
2.2 Female Sexual Dysfunction Treatment Drug Segment by Type
2.2.1 Estrogen Therapy
2.2.2 Ospemifene
2.2.3 Flibanserin
2.2.4 Bremelanotide
2.2.5 Others
2.3 Female Sexual Dysfunction Treatment Drug Sales by Type
2.3.1 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Female Sexual Dysfunction Treatment Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Type (2019-2024)
2.4 Female Sexual Dysfunction Treatment Drug Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce (B2B)
2.4.5 E-Commerce (B2C)
2.5 Female Sexual Dysfunction Treatment Drug Sales by Application
2.5.1 Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Female Sexual Dysfunction Treatment Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Female Sexual Dysfunction Treatment Drug Breakdown Data by Company
3.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Company (2019-2024)
3.1.2 Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company (2019-2024)
3.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Female Sexual Dysfunction Treatment Drug Revenue by Company (2019-2024)
3.2.2 Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company (2019-2024)
3.3 Global Female Sexual Dysfunction Treatment Drug Sale Price by Company
3.4 Key Manufacturers Female Sexual Dysfunction Treatment Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Female Sexual Dysfunction Treatment Drug Product Location Distribution
3.4.2 Players Female Sexual Dysfunction Treatment Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FEMALE SEXUAL DYSFUNCTION TREATMENT DRUG BY GEOGRAPHIC REGION
4.1 World Historic Female Sexual Dysfunction Treatment Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Female Sexual Dysfunction Treatment Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Female Sexual Dysfunction Treatment Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Female Sexual Dysfunction Treatment Drug Sales Growth
4.4 APAC Female Sexual Dysfunction Treatment Drug Sales Growth
4.5 Europe Female Sexual Dysfunction Treatment Drug Sales Growth
4.6 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Growth
5 AMERICAS
5.1 Americas Female Sexual Dysfunction Treatment Drug Sales by Country
5.1.1 Americas Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
5.1.2 Americas Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
5.2 Americas Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
5.3 Americas Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Sexual Dysfunction Treatment Drug Sales by Region
6.1.1 APAC Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024)
6.1.2 APAC Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024)
6.2 APAC Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
6.3 APAC Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Female Sexual Dysfunction Treatment Drug by Country
7.1.1 Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
7.1.2 Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
7.2 Europe Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
7.3 Europe Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Female Sexual Dysfunction Treatment Drug by Country
8.1.1 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Female Sexual Dysfunction Treatment Drug
10.3 Manufacturing Process Analysis of Female Sexual Dysfunction Treatment Drug
10.4 Industry Chain Structure of Female Sexual Dysfunction Treatment Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Female Sexual Dysfunction Treatment Drug Distributors
11.3 Female Sexual Dysfunction Treatment Drug Customer
12 WORLD FORECAST REVIEW FOR FEMALE SEXUAL DYSFUNCTION TREATMENT DRUG BY GEOGRAPHIC REGION
12.1 Global Female Sexual Dysfunction Treatment Drug Market Size Forecast by Region
12.1.1 Global Female Sexual Dysfunction Treatment Drug Forecast by Region (2025-2030)
12.1.2 Global Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Female Sexual Dysfunction Treatment Drug Forecast by Type (2025-2030)
12.7 Global Female Sexual Dysfunction Treatment Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.1.3 Pfizer Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Duchesnay
13.3.1 Duchesnay Company Information
13.3.2 Duchesnay Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.3.3 Duchesnay Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Duchesnay Main Business Overview
13.3.5 Duchesnay Latest Developments
13.4 Sprout Pharmaceuticals
13.4.1 Sprout Pharmaceuticals Company Information
13.4.2 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.4.3 Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sprout Pharmaceuticals Main Business Overview
13.4.5 Sprout Pharmaceuticals Latest Developments
13.5 Cosette Pharmaceuticals
13.5.1 Cosette Pharmaceuticals Company Information
13.5.2 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.5.3 Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Cosette Pharmaceuticals Main Business Overview
13.5.5 Cosette Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
13.6.3 Lupin Female Sexual Dysfunction Treatment Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Female Sexual Dysfunction Treatment Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Female Sexual Dysfunction Treatment Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Estrogen Therapy
Table 4. Major Players of Ospemifene
Table 5. Major Players of Flibanserin
Table 6. Major Players of Bremelanotide
Table 7. Major Players of Others
Table 8. Global Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Table 10. Global Female Sexual Dysfunction Treatment Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Female Sexual Dysfunction Treatment Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Female Sexual Dysfunction Treatment Drug Sale by Application (2019-2024) & (K Units)
Table 14. Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2019-2024)
Table 15. Global Female Sexual Dysfunction Treatment Drug Revenue by Application (2019-2024) & ($ million)
Table 16. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Female Sexual Dysfunction Treatment Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Female Sexual Dysfunction Treatment Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company (2019-2024)
Table 20. Global Female Sexual Dysfunction Treatment Drug Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Female Sexual Dysfunction Treatment Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Female Sexual Dysfunction Treatment Drug Producing Area Distribution and Sales Area
Table 24. Players Female Sexual Dysfunction Treatment Drug Products Offered
Table 25. Female Sexual Dysfunction Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Female Sexual Dysfunction Treatment Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Female Sexual Dysfunction Treatment Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Female Sexual Dysfunction Treatment Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Female Sexual Dysfunction Treatment Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 40. Americas Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 41. APAC Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 42. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 49. Europe Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Female Sexual Dysfunction Treatment Drug
Table 55. Key Market Challenges & Risks of Female Sexual Dysfunction Treatment Drug
Table 56. Key Industry Trends of Female Sexual Dysfunction Treatment Drug
Table 57. Female Sexual Dysfunction Treatment Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Female Sexual Dysfunction Treatment Drug Distributors List
Table 60. Female Sexual Dysfunction Treatment Drug Customer List
Table 61. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Female Sexual Dysfunction Treatment Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Female Sexual Dysfunction Treatment Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Pfizer Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 77. Pfizer Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Teva Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 82. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceuticals Main Business
Table 84. Teva Pharmaceuticals Latest Developments
Table 85. Duchesnay Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Duchesnay Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 87. Duchesnay Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Duchesnay Main Business
Table 89. Duchesnay Latest Developments
Table 90. Sprout Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 92. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sprout Pharmaceuticals Main Business
Table 94. Sprout Pharmaceuticals Latest Developments
Table 95. Cosette Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 97. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cosette Pharmaceuticals Main Business
Table 99. Cosette Pharmaceuticals Latest Developments
Table 100. Lupin Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 102. Lupin Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
Table 1. Female Sexual Dysfunction Treatment Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Female Sexual Dysfunction Treatment Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Estrogen Therapy
Table 4. Major Players of Ospemifene
Table 5. Major Players of Flibanserin
Table 6. Major Players of Bremelanotide
Table 7. Major Players of Others
Table 8. Global Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Table 10. Global Female Sexual Dysfunction Treatment Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Female Sexual Dysfunction Treatment Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Female Sexual Dysfunction Treatment Drug Sale by Application (2019-2024) & (K Units)
Table 14. Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2019-2024)
Table 15. Global Female Sexual Dysfunction Treatment Drug Revenue by Application (2019-2024) & ($ million)
Table 16. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Female Sexual Dysfunction Treatment Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Female Sexual Dysfunction Treatment Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company (2019-2024)
Table 20. Global Female Sexual Dysfunction Treatment Drug Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Female Sexual Dysfunction Treatment Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Female Sexual Dysfunction Treatment Drug Producing Area Distribution and Sales Area
Table 24. Players Female Sexual Dysfunction Treatment Drug Products Offered
Table 25. Female Sexual Dysfunction Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Female Sexual Dysfunction Treatment Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Female Sexual Dysfunction Treatment Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Female Sexual Dysfunction Treatment Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Female Sexual Dysfunction Treatment Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 40. Americas Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 41. APAC Female Sexual Dysfunction Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 42. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Region (2019-2024)
Table 43. APAC Female Sexual Dysfunction Treatment Drug Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 45. APAC Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 46. Europe Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 47. Europe Female Sexual Dysfunction Treatment Drug Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 49. Europe Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 50. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 51. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Type (2019-2024) & (K Units)
Table 53. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales by Application (2019-2024) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Female Sexual Dysfunction Treatment Drug
Table 55. Key Market Challenges & Risks of Female Sexual Dysfunction Treatment Drug
Table 56. Key Industry Trends of Female Sexual Dysfunction Treatment Drug
Table 57. Female Sexual Dysfunction Treatment Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Female Sexual Dysfunction Treatment Drug Distributors List
Table 60. Female Sexual Dysfunction Treatment Drug Customer List
Table 61. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 64. Americas Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Female Sexual Dysfunction Treatment Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 66. APAC Female Sexual Dysfunction Treatment Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Europe Female Sexual Dysfunction Treatment Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 72. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Female Sexual Dysfunction Treatment Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 74. Global Female Sexual Dysfunction Treatment Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. Pfizer Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 77. Pfizer Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Teva Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 82. Teva Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceuticals Main Business
Table 84. Teva Pharmaceuticals Latest Developments
Table 85. Duchesnay Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Duchesnay Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 87. Duchesnay Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Duchesnay Main Business
Table 89. Duchesnay Latest Developments
Table 90. Sprout Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 92. Sprout Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sprout Pharmaceuticals Main Business
Table 94. Sprout Pharmaceuticals Latest Developments
Table 95. Cosette Pharmaceuticals Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 97. Cosette Pharmaceuticals Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cosette Pharmaceuticals Main Business
Table 99. Cosette Pharmaceuticals Latest Developments
Table 100. Lupin Basic Information, Female Sexual Dysfunction Treatment Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Female Sexual Dysfunction Treatment Drug Product Portfolios and Specifications
Table 102. Lupin Female Sexual Dysfunction Treatment Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
LIST OF FIGURES
Figure 1. Picture of Female Sexual Dysfunction Treatment Drug
Figure 2. Female Sexual Dysfunction Treatment Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Female Sexual Dysfunction Treatment Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Female Sexual Dysfunction Treatment Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Female Sexual Dysfunction Treatment Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2023)
Figure 10. Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Estrogen Therapy
Figure 12. Product Picture of Ospemifene
Figure 13. Product Picture of Flibanserin
Figure 14. Product Picture of Bremelanotide
Figure 15. Product Picture of Others
Figure 16. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type in 2023
Figure 17. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Figure 18. Female Sexual Dysfunction Treatment Drug Consumed in Hospital Pharmacies
Figure 19. Global Female Sexual Dysfunction Treatment Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 20. Female Sexual Dysfunction Treatment Drug Consumed in Private Clinics
Figure 21. Global Female Sexual Dysfunction Treatment Drug Market: Private Clinics (2019-2024) & (K Units)
Figure 22. Female Sexual Dysfunction Treatment Drug Consumed in Retail Pharmacies
Figure 23. Global Female Sexual Dysfunction Treatment Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 24. Female Sexual Dysfunction Treatment Drug Consumed in E-Commerce (B2B)
Figure 25. Global Female Sexual Dysfunction Treatment Drug Market: E-Commerce (B2B) (2019-2024) & (K Units)
Figure 26. Female Sexual Dysfunction Treatment Drug Consumed in E-Commerce (B2C)
Figure 27. Global Female Sexual Dysfunction Treatment Drug Market: E-Commerce (B2C) (2019-2024) & (K Units)
Figure 28. Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2023)
Figure 29. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application in 2023
Figure 30. Female Sexual Dysfunction Treatment Drug Sales by Company in 2023 (K Units)
Figure 31. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company in 2023
Figure 32. Female Sexual Dysfunction Treatment Drug Revenue by Company in 2023 ($ millions)
Figure 33. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company in 2023
Figure 34. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 37. Americas Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 38. APAC Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 39. APAC Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 40. Europe Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 41. Europe Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 44. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Country in 2023
Figure 45. Americas Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Figure 46. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 47. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 48. United States Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Region in 2023
Figure 53. APAC Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2024)
Figure 54. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 55. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 56. China Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. India Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. China Taiwan Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Country in 2023
Figure 64. Europe Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Figure 65. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 66. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 67. Germany Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. France Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. UK Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 75. Egypt Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 78. Turkey Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Female Sexual Dysfunction Treatment Drug in 2023
Figure 81. Manufacturing Process Analysis of Female Sexual Dysfunction Treatment Drug
Figure 82. Industry Chain Structure of Female Sexual Dysfunction Treatment Drug
Figure 83. Channels of Distribution
Figure 84. Global Female Sexual Dysfunction Treatment Drug Sales Market Forecast by Region (2025-2030)
Figure 85. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Female Sexual Dysfunction Treatment Drug
Figure 2. Female Sexual Dysfunction Treatment Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Female Sexual Dysfunction Treatment Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Female Sexual Dysfunction Treatment Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Female Sexual Dysfunction Treatment Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2023)
Figure 10. Female Sexual Dysfunction Treatment Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Estrogen Therapy
Figure 12. Product Picture of Ospemifene
Figure 13. Product Picture of Flibanserin
Figure 14. Product Picture of Bremelanotide
Figure 15. Product Picture of Others
Figure 16. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Type in 2023
Figure 17. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Type (2019-2024)
Figure 18. Female Sexual Dysfunction Treatment Drug Consumed in Hospital Pharmacies
Figure 19. Global Female Sexual Dysfunction Treatment Drug Market: Hospital Pharmacies (2019-2024) & (K Units)
Figure 20. Female Sexual Dysfunction Treatment Drug Consumed in Private Clinics
Figure 21. Global Female Sexual Dysfunction Treatment Drug Market: Private Clinics (2019-2024) & (K Units)
Figure 22. Female Sexual Dysfunction Treatment Drug Consumed in Retail Pharmacies
Figure 23. Global Female Sexual Dysfunction Treatment Drug Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 24. Female Sexual Dysfunction Treatment Drug Consumed in E-Commerce (B2B)
Figure 25. Global Female Sexual Dysfunction Treatment Drug Market: E-Commerce (B2B) (2019-2024) & (K Units)
Figure 26. Female Sexual Dysfunction Treatment Drug Consumed in E-Commerce (B2C)
Figure 27. Global Female Sexual Dysfunction Treatment Drug Market: E-Commerce (B2C) (2019-2024) & (K Units)
Figure 28. Global Female Sexual Dysfunction Treatment Drug Sale Market Share by Application (2023)
Figure 29. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Application in 2023
Figure 30. Female Sexual Dysfunction Treatment Drug Sales by Company in 2023 (K Units)
Figure 31. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Company in 2023
Figure 32. Female Sexual Dysfunction Treatment Drug Revenue by Company in 2023 ($ millions)
Figure 33. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Company in 2023
Figure 34. Global Female Sexual Dysfunction Treatment Drug Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 37. Americas Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 38. APAC Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 39. APAC Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 40. Europe Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 41. Europe Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Female Sexual Dysfunction Treatment Drug Revenue 2019-2024 ($ millions)
Figure 44. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Country in 2023
Figure 45. Americas Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Figure 46. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 47. Americas Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 48. United States Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Region in 2023
Figure 53. APAC Female Sexual Dysfunction Treatment Drug Revenue Market Share by Region (2019-2024)
Figure 54. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 55. APAC Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 56. China Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. India Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. China Taiwan Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Country in 2023
Figure 64. Europe Female Sexual Dysfunction Treatment Drug Revenue Market Share by Country (2019-2024)
Figure 65. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 66. Europe Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 67. Germany Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. France Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. UK Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Type (2019-2024)
Figure 74. Middle East & Africa Female Sexual Dysfunction Treatment Drug Sales Market Share by Application (2019-2024)
Figure 75. Egypt Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 78. Turkey Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries Female Sexual Dysfunction Treatment Drug Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Female Sexual Dysfunction Treatment Drug in 2023
Figure 81. Manufacturing Process Analysis of Female Sexual Dysfunction Treatment Drug
Figure 82. Industry Chain Structure of Female Sexual Dysfunction Treatment Drug
Figure 83. Channels of Distribution
Figure 84. Global Female Sexual Dysfunction Treatment Drug Sales Market Forecast by Region (2025-2030)
Figure 85. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 86. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Forecast by Type (2025-2030)
Figure 87. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 88. Global Female Sexual Dysfunction Treatment Drug Sales Market Share Forecast by Application (2025-2030)
Figure 89. Global Female Sexual Dysfunction Treatment Drug Revenue Market Share Forecast by Application (2025-2030)
